Insider Transactions in Q3 2021 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2021
|
Daniel Pichl Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,320
+20.08%
|
$99,760
$43.1 P/Share
|
|
Aug 10
2021
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-17.15%
|
$70,000,000
$70.25 P/Share
|
|
Jul 20
2021
|
Saqib Islam Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,572
-2.21%
|
$1,430,044
$77.68 P/Share
|
|
Jul 19
2021
|
Saqib Islam Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
43,928
-4.97%
|
$3,338,528
$76.09 P/Share
|
|
Jul 13
2021
|
L. Mary Smith Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.63%
|
$800,000
$80.88 P/Share
|
|
Jul 13
2021
|
L. Mary Smith Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.33%
|
$20,000
$2.3 P/Share
|
|
Jul 01
2021
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,959
-0.26%
|
$1,356,515
$85.01 P/Share
|
|
Jul 01
2021
|
Badreddin Edris Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
32,000
-9.59%
|
$2,720,000
$85.35 P/Share
|